Icahn Issues Statement Regarding Amylin Pharmaceuticals
NEW YORK, April 25, 2012 /PRNewswire/ -- Carl C. Icahn today announced that his affiliates had voluntarily dismissed their lawsuit against Amylin Pharmaceuticals which had sought an extension of the deadline to nominate directors at the 2012 annual meeting of shareholders. Mr. Icahn released the following statement:
The decision to discontinue our lawsuit seeking to extend the director nomination deadline was the result of discussions I had with Daniel Bradbury, Amylin's chief executive officer, that we agreed would not be publicly disclosed.
Mr. Icahn reiterated that he continues to strongly believe that the company should be sold at this time.
SOURCE Carl C. Icahn
More by this Source
Icahn Files Brief To Expedite Proceedings Against Dell Inc. And Dell's Board Of Directors
Aug 05, 2013, 12:57 ET
Icahn Comments On Latest Dell Machinations
Aug 02, 2013, 13:40 ET
Icahn Commences Litigation In Delaware Court Against Dell Inc. And Dell's Board Of Directors
Aug 01, 2013, 14:10 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.